Skip to content

NORVEX

Active Risk: not assessed Private limited companyfounded 2026active for less than a yearMeulesteedsesteenweg 452, 9000 GhentKBO/BCE: BE 1038.915.134
NORVEX
Follow ReportCompare

Board

2 directors, no change since June 2026
Putnoki Ivan
Director
since 13-06-2026
SEVER Cebrail
Director
appointed by deed of 15-06-2026 term without a fixed end
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each director alone
deed of 15-06-2026

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today
Putnoki Ivan
Director
SEVER Cebrail
Director
BoardEarliermandate already running before its first mention
Mandates as a list
  • Putnoki Ivan
    • Director, from 13-06-2026 to date
  • SEVER Cebrail
    • Director, until 13-06-2026
    • Director, appointed by deed of 15-06-2026, still in office

Control

Shares transferred to
Putnoki Ivan
This company
NORVEX

Capital

Contribution
€500
Shares
100
Contribution per share
€5
Source
deed of 15-06-2026

Articles of association

deed of 15-06-2026 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Financial yearThe company draws up its annual accounts over this twelve-month period.
From 1 July to 30 June
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Third Friday of December at 12:00 (the first on 17-12-2027)

Shareholders

Share transfer deed of 21-09-2026 ↗
At incorporation deed of 15-06-2026 ↗

Next steps

See this company's board, registered office and name on a given date.Company as of a date See what became of the directors' other companies.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file

We would like to set cookies. That happens only with your consent. What we measure